17-76002392-G-A

Variant summary

Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong

The NM_001258.4(CDK3):​c.460G>A​(p.Val154Met) variant causes a missense change. The variant allele was found at a frequency of 0.000314 in 1,612,476 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: 𝑓 0.00032 ( 0 hom., cov: 32)
Exomes 𝑓: 0.00031 ( 1 hom. )

Consequence

CDK3
NM_001258.4 missense

Scores

2
9
8

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 6.84
Variant links:
Genes affected
CDK3 (HGNC:1772): (cyclin dependent kinase 3) This gene encodes a member of the cyclin-dependent protein kinase family. The protein promotes entry into S phase, in part by activating members of the E2F family of transcription factors. The protein also associates with cyclin C and phosphorylates the retinoblastoma 1 protein to promote exit from G0. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Likely_benign. Variant got -2 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.023290426).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
CDK3NM_001258.4 linkuse as main transcriptc.460G>A p.Val154Met missense_variant 5/8 ENST00000448471.3 NP_001249.1
TEN1-CDK3NR_037709.1 linkuse as main transcriptn.2296G>A non_coding_transcript_exon_variant 7/10

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
CDK3ENST00000448471.3 linkuse as main transcriptc.460G>A p.Val154Met missense_variant 5/85 NM_001258.4 ENSP00000400088 P1
CDK3ENST00000425876.6 linkuse as main transcriptc.460G>A p.Val154Met missense_variant 4/71 ENSP00000410561 P1
CDK3ENST00000586261.2 linkuse as main transcriptc.340G>A p.Val114Met missense_variant 3/55 ENSP00000465062

Frequencies

GnomAD3 genomes
AF:
0.000316
AC:
48
AN:
152050
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0000483
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00577
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000208
Gnomad FIN
AF:
0.0000944
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000338
Gnomad OTH
AF:
0.000479
GnomAD3 exomes
AF:
0.000368
AC:
92
AN:
249920
Hom.:
1
AF XY:
0.000400
AC XY:
54
AN XY:
135158
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00457
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.0000654
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000370
Gnomad OTH exome
AF:
0.000327
GnomAD4 exome
AF:
0.000314
AC:
459
AN:
1460308
Hom.:
1
Cov.:
32
AF XY:
0.000310
AC XY:
225
AN XY:
726464
show subpopulations
Gnomad4 AFR exome
AF:
0.0000299
Gnomad4 AMR exome
AF:
0.0000671
Gnomad4 ASJ exome
AF:
0.00432
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.000104
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.000272
Gnomad4 OTH exome
AF:
0.000431
GnomAD4 genome
AF:
0.000315
AC:
48
AN:
152168
Hom.:
0
Cov.:
32
AF XY:
0.000269
AC XY:
20
AN XY:
74410
show subpopulations
Gnomad4 AFR
AF:
0.0000482
Gnomad4 AMR
AF:
0.00
Gnomad4 ASJ
AF:
0.00577
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.000208
Gnomad4 FIN
AF:
0.0000944
Gnomad4 NFE
AF:
0.000338
Gnomad4 OTH
AF:
0.000474
Alfa
AF:
0.000677
Hom.:
0
Bravo
AF:
0.000306
TwinsUK
AF:
0.00
AC:
0
ALSPAC
AF:
0.000519
AC:
2
ESP6500AA
AF:
0.00
AC:
0
ESP6500EA
AF:
0.000349
AC:
3
ExAC
AF:
0.000420
AC:
51
EpiCase
AF:
0.000709
EpiControl
AF:
0.000178

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsJan 03, 2024The c.460G>A (p.V154M) alteration is located in exon 5 (coding exon 4) of the CDK3 gene. This alteration results from a G to A substitution at nucleotide position 460, causing the valine (V) at amino acid position 154 to be replaced by a methionine (M). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Uncertain
0.38
BayesDel_addAF
Benign
-0.086
T
BayesDel_noAF
Uncertain
-0.040
CADD
Benign
22
DANN
Pathogenic
1.0
DEOGEN2
Benign
0.13
T;T;T;.
Eigen
Uncertain
0.53
Eigen_PC
Uncertain
0.56
FATHMM_MKL
Pathogenic
0.99
D
LIST_S2
Uncertain
0.96
D;D;.;D
M_CAP
Benign
0.042
D
MetaRNN
Benign
0.023
T;T;T;T
MetaSVM
Benign
-0.53
T
MutationAssessor
Benign
0.85
.;L;L;.
MutationTaster
Benign
1.0
D;D
PrimateAI
Uncertain
0.77
T
PROVEAN
Benign
-1.7
.;N;N;.
REVEL
Uncertain
0.34
Sift
Uncertain
0.0010
.;D;D;.
Sift4G
Uncertain
0.014
D;D;D;D
Polyphen
0.97
.;D;D;.
Vest4
0.80
MVP
0.53
MPC
0.89
ClinPred
0.20
T
GERP RS
4.5
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Varity_R
0.39
gMVP
0.34

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs145748425; hg19: chr17-73998473; API